Clinical Trial Supplies Market by Therapeutic, Products & Services - 2020


Posted October 26, 2017 by Sandeepguha21

Clinical Trial Supplies Market, By Products & Services (Logistics & Distribution, Manufacturing, Packaging & Labelling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas

 
Clinical Trial Supplies Market, By Products & Services (Logistics & Distribution, Manufacturing, Packaging & Labelling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorder, Cardiovascular, Oncology)-Global Forecast to 2020
The global clinical trial supplies market consists of various products and services that are used in clinical trials. This market is driven by several factors such as globalization of clinical trial activities, increasing R&D investments and government support, rising incidences of various diseases, and increasing expansion activities by CROs. Increasing patent expiry, the development of generic drugs, and high potential growth in emerging markets are all factors that have opened an array of opportunities for the clinical trial supplies market. However, factors such as longer approval times for clinical trials are hampering the growth of the global clinical trial supplies market.
http://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html
The clinical trial supplies market is expected to reach USD 1,274.3 million by 2020 from USD 904.3 million in 2015, at a CAGR of 7.1%. This market is segmented based on products and services, phases, therapeutic areas, and regions.
Based on products and services, the clinical trial supplies market is segmented into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the market in 2015. Globalization of clinical trials and increasing outsourcing services will drive the growth of this market segment.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=172240059
Based on phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of this market. Growth in this segment can be attributed to the large sample size of patients and high cost of phase III trials.
Based on therapeutic areas, the clinical trial supplies market is segmented into oncology, cardiovascular diseases, respiratory diseases, central nervous system (CNS) and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the market in 2015. Increase in cancer incidences and government funding for cancer research are factors driving the growth of this market.

FIGURE 1 CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2015

Source: World Health Organization (WHO), the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), Generics and Biosimilars Initiative (GaBI), American Association of Pharmaceutical Scientists (AAPS), Generic Pharmaceutical Association (GPhA), Food and Drug Administration (FDA), Committee for Medicinal Products for Human Use (CHMP), ClinicalTrials.gov, the Association of International CROs (AICROS), Association of Clinical Research Organization (ACRO), Association of Clinical Research Professionals (ACRP), Society for Clinical Trials (SCT), American Association for Cancer Research (AACR), American Federation for Medical Research (AFMR), Indian Society for Clinical Research (ISCR), Expert Interviews, and MarketsandMarkets Analysis

The global clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America will continue to dominate the global clinical trial supplies market in the forecast period. However, Asia-Pacific is expected to witness the highest CAGR, with the growth in this market centered at China, India, and Japan.
The major players in this market include Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketsandMarkets™
Website MarketsandMarkets™
Phone 1-888-600-6441
Business Address MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441
Country India
Categories Health
Tags clinical trial supplies market
Last Updated October 26, 2017